Interplay of primary sequence, position and secondary RNA structure determines alternative splicing of LMNA in a pre-mature aging syndrome.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
20 06 2019
Historique:
accepted: 01 04 2019
revised: 25 03 2019
received: 16 02 2019
pubmed: 23 4 2019
medline: 4 12 2019
entrez: 23 4 2019
Statut: ppublish

Résumé

Aberrant splicing in exon 11 of the LMNA gene causes the premature aging disorder Hutchinson-Gilford Progeria Syndrome. A de novo C1824T mutation activates an internal alternative 5' splice site, resulting in formation of the disease-causing progerin protein. The underlying mechanism for this 5' splice site selection is unknown. Here, we have applied a combination of targeted mutational analysis in a cell-based system and structural mapping by SHAPE-MaP to comprehensively probe the contributions of primary sequence, secondary RNA structure and linear splice site position in determining in vivo mechanisms of splice site choice in LMNA. While splice site choice is in part defined by sequence complementarity to U1 snRNA, we identify RNA secondary structural elements near the alternative 5' splice sites and show that splice site choice is significantly influenced by the structural context of the available splice sites. Furthermore, relative positioning of the competing sites within the primary sequence of the pre-mRNA is a predictor of 5' splice site usage, with the distal position favored over the proximal, regardless of sequence composition. Together, these results demonstrate that 5' splice site selection in LMNA is determined by an intricate interplay among RNA sequence, secondary structure and splice site position.

Identifiants

pubmed: 31006814
pii: 5475939
doi: 10.1093/nar/gkz259
pmc: PMC6582319
doi:

Substances chimiques

LMNA protein, human 0
Lamin Type A 0
Nuclear Proteins 0
RNA Splice Sites 0
RNA, Small Nuclear 0
U1 small nuclear RNA 0
RNA 63231-63-0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5922-5935

Informations de copyright

Published by Oxford University Press on behalf of Nucleic Acids Research 2019.

Références

Nat Genet. 2008 Dec;40(12):1413-5
pubmed: 18978789
Nat Protoc. 2015 Nov;10(11):1643-69
pubmed: 26426499
Cell. 1986 Aug 29;46(5):681-90
pubmed: 2427200
Nat Methods. 2014 Sep;11(9):959-65
pubmed: 25028896
Nat Rev Genet. 2010 May;11(5):345-55
pubmed: 20376054
Hum Mutat. 2007 Feb;28(2):150-8
pubmed: 17001642
Nature. 2010 Jan 28;463(7280):457-63
pubmed: 20110989
Genes Dev. 1994 Nov 15;8(22):2704-17
pubmed: 7958927
Cell. 1990 Jul 13;62(1):25-34
pubmed: 2163768
Genes Dev. 2013 Jan 15;27(2):129-44
pubmed: 23348838
EMBO J. 1993 Sep;12(9):3607-17
pubmed: 8253084
Nature. 2003 May 15;423(6937):293-8
pubmed: 12714972
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Cell. 2014 Jan 30;156(3):400-7
pubmed: 24485450
Trends Biochem Sci. 2010 Mar;35(3):169-78
pubmed: 19959365
Biochem J. 2010 Sep 15;430(3):379-92
pubmed: 20795951
Hum Mol Genet. 2009 Jul 1;18(13):2462-71
pubmed: 19376814
Cell. 1986 Sep 12;46(6):827-35
pubmed: 3757028
Hum Mol Genet. 2011 Dec 1;20(23):4540-55
pubmed: 21875900
J Mol Biol. 1991 Jan 20;217(2):265-81
pubmed: 1825120
Cell. 2008 Dec 26;135(7):1224-36
pubmed: 19109894
Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5002-7
pubmed: 15753297
Curr Protoc Bioinformatics. 2006 Mar;Chapter 12:Unit 12.6
pubmed: 18428759
Science. 2006 May 19;312(5776):1059-63
pubmed: 16645051
Nat Med. 2005 Apr;11(4):440-5
pubmed: 15750600
J Biol Chem. 2006 Aug 18;281(33):23302-6
pubmed: 16782711
Mol Cell Biol. 2010 Apr;30(8):1878-86
pubmed: 20123971
Bioinformatics. 2009 Aug 1;25(15):1974-5
pubmed: 19398448
Nature. 1986 Nov 20-26;324(6094):280-2
pubmed: 2946960
RNA. 2005 May;11(5):683-98
pubmed: 15840817
Mol Cell. 2018 Sep 20;71(6):1012-1026.e3
pubmed: 30174293
Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2642-6
pubmed: 7708698
RNA Biol. 2011 May-Jun;8(3):450-7
pubmed: 21558794
Science. 2003 Jun 27;300(5628):2055
pubmed: 12702809
Cell. 1991 Jul 26;66(2):373-82
pubmed: 1855257
Methods Mol Biol. 2016;1490:15-34
pubmed: 27665590
Nat Rev Genet. 2016 Jan;17(1):19-32
pubmed: 26593421

Auteurs

Asaf Shilo (A)

Cell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Frances Anne Tosto (FA)

Cell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Jason W Rausch (JW)

Basic Research Laboratory, National Cancer Institute, NIH, Frederick, MD 21702, USA.

Stuart F J Le Grice (SFJ)

Basic Research Laboratory, National Cancer Institute, NIH, Frederick, MD 21702, USA.

Tom Misteli (T)

Cell Biology of Genomes, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH